| Line Item | 2023-09-29 | Y/Y |
|---|---|---|
| Revenue | $16.03B | -1.5% |
| Cost of Revenue | $10.98B | -0.5% |
| Gross Profit | $5.05B | -3.6% |
| R&D Expense | $593.0M | -2.8% |
| SG&A Expense | $1.67B | +5.4% |
| Operating Income | $2.30B | -16.4% |
| Interest Expense | $80.0M | +21.2% |
| Pre-tax Income | $2.27B | -17.0% |
| Income Tax | $364.0M |
| Line Item | 2023-09-29 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.66B | +52.7% |
| Accounts Receivable | $2.97B | +3.6% |
| Inventory | $2.55B | -4.6% |
| Current Assets | $7.89B | +8.6% |
| Total Assets | $21.71B | +4.5% |
| Current Liabilities | $4.46B | -3.6% |
| Long-term Debt | $3.53B | +7.2% |
| Line Item | 2023-09-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.13B | +26.9% |
| Capital Expenditures | $732.0M | -4.7% |
| Investing Cash Flow | -$768.0M | +12.5% |
| Financing Cash Flow | -$1.79B | -6.5% |
| Free Cash Flow | $2.40B | +41.2% |
| +19.0% |
| Net Income | $1.91B | -21.3% |
| EPS (Basic) | $6.06 | -19.4% |
| EPS (Diluted) | $6.03 | -19.3% |
| Total Liabilities |
| $10.06B |
| +1.7% |
| Stockholders' Equity | $11.55B | +6.9% |